HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bao-Guo Xiao Selected Research

Synucleins

1/2022The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson' disease mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bao-Guo Xiao Research Topics

Disease

26Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 08/2004
14Multiple Sclerosis
12/2022 - 06/2003
13Demyelinating Diseases (Demyelinating Disease)
11/2021 - 06/2010
10Inflammation (Inflammations)
01/2022 - 04/2002
10Neuroinflammatory Diseases
01/2020 - 05/2011
8Autoimmune Diseases (Autoimmune Disease)
02/2008 - 01/2003
6Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022 - 05/2012
6Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
01/2019 - 12/2002
5Hypoxia (Hypoxemia)
01/2017 - 01/2009
4Alzheimer Disease (Alzheimer's Disease)
12/2022 - 01/2017
4Parkinson Disease (Parkinson's Disease)
12/2022 - 01/2017
4Nervous System Diseases (Neurological Disorders)
11/2018 - 11/2007
4Neoplasms (Cancer)
11/2018 - 01/2003
4Body Weight (Weight, Body)
01/2018 - 03/2003
4Myasthenia Gravis
06/2012 - 08/2004
4Brain Ischemia (Cerebral Ischemia)
11/2007 - 04/2002
3Necrosis
11/2018 - 08/2005
3Stroke (Strokes)
02/2014 - 05/2007
2Disease Progression
01/2021 - 11/2012
2Atrophy
01/2019 - 01/2019
2Weight Loss (Weight Reduction)
01/2012 - 12/2011
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2003 - 04/2002
1Pyelonephritis
07/2019
1Atherosclerosis
01/2019
1Memory Disorders (Memory Loss)
01/2017
1Parkinsonian Disorders (Parkinsonism)
12/2016
1Movement Disorders (Movement Disorder)
12/2016
1Brain Diseases (Brain Disorder)
03/2016
1Encephalomyelitis (Myeloencephalitis)
01/2015
1Lactic Acidosis
02/2014
1Mitochondrial encephalopathy
02/2014
1MELAS Syndrome (Syndrome, MELAS)
02/2014

Drug/Important Bio-Agent (IBA)

22fasudil (AT 877)IBA
12/2022 - 11/2009
13rho-Associated KinasesIBA
12/2022 - 02/2010
9Therapeutic UsesIBA
12/2022 - 08/2004
9CuprizoneIBA
11/2021 - 01/2019
7Neuroprotective AgentsIBA
01/2022 - 05/2007
6CytokinesIBA
01/2017 - 01/2003
5Cholinergic ReceptorsIBA
02/2008 - 03/2003
4AutoantibodiesIBA
01/2022 - 08/2004
4ginkgolide KIBA
01/2022 - 05/2019
4Myelin Basic ProteinIBA
01/2020 - 08/2005
4Myelin-Oligodendrocyte GlycoproteinIBA
01/2019 - 06/2010
4AntibodiesIBA
08/2004 - 12/2002
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2022 - 12/2016
3Interleukin-6 (Interleukin 6)IBA
12/2019 - 05/2011
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
09/2007 - 01/2005
3Peptides (Polypeptides)IBA
08/2007 - 01/2003
2bilobalideIBA
01/2020 - 01/2019
2hydroxyfasudilIBA
01/2020 - 01/2019
2NF-kappa B (NF-kB)IBA
12/2019 - 10/2019
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 02/2008
2InterleukinsIBA
11/2018 - 08/2005
2CannabinoidsIBA
01/2018 - 12/2011
2RimonabantIBA
01/2018 - 01/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 11/2009
2Oxygen (Dioxygen)IBA
01/2017 - 11/2009
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2016 - 01/2012
2EndocannabinoidsIBA
01/2012 - 12/2011
2LigandsIBA
05/2011 - 08/2005
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2007 - 05/2007
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2007 - 06/2003
2Interleukin-4 (Interleukin 4)IBA
09/2007 - 06/2003
2Transforming Growth Factor beta (TGF-beta)IBA
01/2005 - 11/2004
2Estrogens (Estrogen)FDA Link
11/2004 - 09/2004
1Biological ProductsIBA
12/2022
1wuzi yanzongIBA
01/2022
1SynucleinsIBA
01/2022
1ethyl pyruvateIBA
01/2021
1Nerve Growth Factor (NGF)IBA
01/2020
1Ciliary Neurotrophic Factor (CNTF)IBA
01/2020
1Black-GoldIBA
01/2020
1Luxol Fast Blue MBS (Luxol fast blue)IBA
01/2020
1Platelet Activating FactorIBA
05/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Nerve Growth Factors (Neurotrophins)IBA
01/2019
1myelin oligodendrocyte glycoprotein (35-55)IBA
01/2019
1AntioxidantsIBA
11/2018
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2018
1GraphiteIBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1tau Proteins (tau Protein)IBA
01/2017
1Presenilin-1IBA
01/2017
1EnzymesIBA
01/2017
1Small Interfering RNA (siRNA)IBA
12/2016
1Free RadicalsIBA
03/2016
1Protein AggregatesIBA
02/2016
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
02/2015
1TrehaloseIBA
11/2014
1Mitochondrial DNA (mtDNA)IBA
02/2014
1Leu Transfer RNAIBA
02/2014
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
01/2013

Therapy/Procedure

10Therapeutics
10/2019 - 01/2003
5Immunotherapy
08/2004 - 01/2003
4Immunomodulation
01/2022 - 11/2007
1Intraperitoneal Injections
01/2019
1Communication Aids for Disabled (TDD)
01/2019
1Injections
10/2014